| |
|
|
|
Catalyst Biosciences Inc.  
|
|
9.42 -0.28 (-0.03%) |
03-21 11:45 |
|
Open: |
9.63 |
Pre close: |
9.7 |
Target:
|
11.55
|
|
High: |
9.89 |
Low: |
9.27 |
Resistance:
|
9.89
11.55
|
|
Volume: |
43,043 |
Market Cap: |
113M |
Support:
|
8.43
7.52
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.56
 |
MACD |
MACD(12,26):
|
0.28 |
|
MA(20): |
8.85 |
Signal(12,26,9): |
0.16 |
|
MA(100): |
9.11 |
Stochastic Oscillator |
%K(14,3):
|
89.53  |
|
MA(250): |
13.55 |
%D(3): |
92.58 |
|
Average Volume(K) |
3-Month: |
23414
|
52-Week |
High:
|
29.95 |
|
10-Days: |
19863 |
Low: |
6.20 |
|
RSI |
RSI(14):
|
58.83 |
Change(%): |
-66.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.650 |
Return on Equity (ttm) |
-39.9 |
Shares Out. (M) |
11.97 |
|
EPS Est. Current Year |
-7.910 |
Return on Assets (ttm) |
-36.6 |
Shares Float (M) |
11.59 |
|
EPS Est. Next Year |
-4.810 |
PEG Ratio |
0.09 |
% Held by Insiders |
6.50 |
|
EPS Est. Next Quarter |
-1.550 |
Qtrly Rev. Growth |
-100.0 |
% Held by Institutions |
76.00 |
|
Forward EPS |
-4.863 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.910 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.57 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
10.38 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.55 |
P/S |
0.00 |
|
Operating Margin |
-562033.31 |
Levered Free Cash Flow
(M) |
-14.75 |
P/CF |
-3.96 |
|
|
|
|
|
|
